Embryo Cryopreservation as an Alternative to Treat Infertility in Breast Cancer Survivors in Reproductive Age: Case Reports
Introduction: Chemotherapy has been shown to reduce breast cancer (BC) mortality significantly. However, several types of chemotherapy drugs affect the reproductive system. As BC has become increasingly prevalent, many young women are diagnosed during their reproductive years. As a result, overcoming chemotherapy-related infertility is becoming increasingly important. Hence, in-vitro fertilization (IVF) with embryo cryopreservation before chemotherapy is considered a way to preserve future reproductive potential. For this reason, this paper aims to report the cases of safe pregnancy in BC survivors through pre-chemotherapy IVF followed by embryo cryopreservation.
Case Presentation: Two women, aged 35 and 29, respectively, were treated for BC by surgery, chemotherapy, and tamoxifen. They performed in-vitro fertilization (IVF) with embryo cryopreservation before chemotherapy. Their pregnancy was completed without complications, and they gave birth to healthy babies. Their last oncological visit also showed no signs of cancer recurrence, showing disease-free intervals of seven and eight years, respectively.
Conclusions: Pre-chemotherapy IVF followed by embryo cryopreservation can be an alternative to treat infertility in BC survivors of reproductive age who are receiving chemotherapy.
Breast cancer [Internet]. [cited 2022 Mar 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
Muñoz M, Santaballa A, Seguí MA, et al. SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016). Clin Transl Oncol. 2016 Dec 1;18(12):1229.
Shapira M, Raanani H, Meirow D. IVF for fertility preservation in breast cancer patients—efficacy and safety issues. J Assist Reprod Genet. 2015 August 4;32(8):1171.
Meirow D, Biederman H, Anderson RA, Wallace WHB. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010 Dec;53(4):727–39.
Bedoschi G, Navarro PA, Oktay K. Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncol. 2016 Oct 1;12(20):2333–44.
Partridge AH, Ruddy KJ. Fertility and adjuvant treatment in young women with breast cancer. Breast. 2007;16 Suppl 2(2 SUPPL.):175–81.
Penault-Llorca F, André F, Sagan C, et al. Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer. J Clin Oncol. 2009 June 10;27(17):2809–15.
Dittrich R, Kliesch S, Schüring A, et al. Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women. Geburtshilfe Frauenheilkd. 2018 Jun 1;78(6):567–84.
Alshami HAA, Kadasne AR, Khalfan M, et al. Pregnancy outcome in late maternal age in a high-income developing country. Arch Gynecol Obstet. 2011;284(5):1113–6.
Moragón S, Di Liello R, Bermejo B, et al. Fertility and breast cancer: A literature review of counseling, preservation options and outcomes. Crit Rev Oncol Hematol. 2021 October 1;166.
Salama M, Woodruff TK. Anticancer Treatments and Female Fertility: Clinical Concerns and Role of Oncologists in Oncofertility Practice. Expert Rev Anticancer Ther. 2017 August 3;17(8):687.
Vuković P, Kasum M, Raguž J, et al. Fertility Preservation In Young Women With Early-Stage Breast Cancer. Acta Clin Croat. 2019;58(1):147.
Carneiro MM, Cota AM, Amaral MC, et al. Motherhood after breast cancer: can we balance fertility preservationand cancer treatment? A narrative review of the literature. JBRA Assist Reprod. 2018;22(3):244.
Oktay K, Oktem O, Reh A, Vahdat L. Measuring the impact of chemotherapy on fertility in women with breast cancer. J Clin Oncol. 2006 Aug 20;24(24):4044–6.
Chen ZJ, Shi Y, Sun Y, et al. Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome. N Engl J Med. 2016 August 11;375(6):523–33.
Cho HW, Lee S, Min KJ, et al. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity. Int J Mol Sci. 2020 Oct 21;21(20):7792.
Cardoso F, Loibl S, Pagani O, et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012 Dec;48(18):3355–77.
Zervoudis S, Iatrakis G, Navrozoglou I. Reproduction after breast cancer. Best Pract Res Clin Obstet Gynaecol. 2010 Feb;24(1):81–6.
Braems G, Denys H, De Wever O, et al. Use of tamoxifen before and during pregnancy. Oncologist. 2011 Nov 1;16(11):1547–51.
De Pedro M, Otero B, Martín B. Fertility preservation and breast cancer: a review. Ecancermedicalscience. 2015 Feb 3;9.
Raphael J, Trudeau ME, Chan K. Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature. Curr Oncol. 2015 March 1;22(Suppl 1):S8.
Bjelic-Radisic V, Esfandbod M, Alipour S. Pregnancy in breast cancer survivors. Adv Exp Med Biol. 2020;1252:165–74.
Nye L, Rademaker A, Gradishar WJ. Breast cancer outcomes after diagnosis of hormone positive breast cancer and subsequent pregnancy in the tamoxifen era. Clin Breast Cancer. 2017 Jul 1;17(4):e185.
Upponi SS, Ahmad F, Whitaker IS, Purushotham AD. Pregnancy after breast cancer. Eur J Cancer. 2003;39(6):736–41.
Anderson RA, Brewster DH, Wood R, et al. The impact of cancer on subsequent chance of pregnancy: a population-based analysis. Hum Reprod. 2018 July 1;33(7):1281–90.
Dow KH, Kuhn D. Fertility options in young breast cancer survivors: a review of the literature. Oncol Nurs Forum. 2004 May;31(3).
Azim HA, Bellettini G, Liptrott SJ, et al. Breastfeeding in breast cancer survivors: Pattern, behaviour and effect on breast cancer outcome. Breast. 2010;19(6):527–31.
Article MetricsAbstract view : 139 times
PDF - 58 times
- There are currently no refbacks.
Copyright (c) 2022 Indonesian Journal of Cancer